$ORGO
Organogenesis Holdings Inc.

2019 Q4 Form 10-Q Financial Statement

#000119312519289983 Filed on November 12, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $74.60M $64.27M $50.77M
YoY Change 17.3% 26.58% -1.34%
Cost Of Revenue $20.40M $19.13M $19.48M
YoY Change 16.5% -1.78% 21.07%
Gross Profit $54.30M $45.13M $31.29M
YoY Change 17.82% 44.23% -11.53%
Gross Profit Margin 72.79% 70.23% 61.64%
Selling, General & Admin $52.40M $49.48M $38.58M
YoY Change 10.37% 28.23% 8.19%
% of Gross Profit 96.5% 109.62% 123.3%
Research & Development $3.600M $3.924M $2.779M
YoY Change 16.47% 41.2% 19.53%
% of Gross Profit 6.63% 8.69% 8.88%
Depreciation & Amortization $2.350M $792.0K $861.0K
YoY Change -66.33% -8.01%
% of Gross Profit 4.33% 1.75% 2.75%
Operating Expenses $56.00M $53.40M $41.36M
YoY Change 10.74% 29.1% 8.88%
Operating Profit -$1.700M -$8.265M -$10.07M
YoY Change -62.05% -17.92% 284.94%
Interest Expense -$2.600M $2.427M $2.940M
YoY Change -197.63% -17.45% 31.66%
% of Operating Profit
Other Income/Expense, Net $0.00 -$2.428M -$2.981M
YoY Change -100.0% -18.55% 8.8%
Pretax Income -$4.400M -$10.69M -$13.05M
YoY Change -52.45% -18.07% 143.67%
Income Tax $0.00 $48.00K $27.00K
% Of Pretax Income
Net Earnings -$4.400M -$10.74M -$13.08M
YoY Change -52.46% -17.87% 142.05%
Net Earnings / Revenue -5.9% -16.71% -25.76%
Basic Earnings Per Share -$0.12
Diluted Earnings Per Share -$44.99K -$0.12 $494.9K
COMMON SHARES
Basic Shares Outstanding 94.74M 92.28M
Diluted Shares Outstanding 92.28M

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.20M $23.00M $0.00
YoY Change 182.63% -100.0%
Cash & Equivalents $60.37M $23.16M $25.89M
Short-Term Investments
Other Short-Term Assets $3.200M $3.300M $0.00
YoY Change 33.33% -100.0%
Inventory $22.92M $20.18M
Prepaid Expenses $2.953M
Receivables $39.36M $34.38M
Other Receivables $0.00 $0.00
Total Short-Term Assets $125.6M $80.84M $0.00
YoY Change 76.58% -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment $47.18M $44.25M
YoY Change 19.08%
Goodwill $25.54M $25.54M
YoY Change 0.0%
Intangibles $20.80M $22.31M
YoY Change -20.29%
Long-Term Investments
YoY Change
Other Assets $884.0K $916.0K $316.3M
YoY Change 52.68% -99.71% 1.48%
Total Long-Term Assets $95.09M $93.80M $316.3M
YoY Change 2.74% -70.35% 1.48%
TOTAL ASSETS
Total Short-Term Assets $125.6M $80.84M $0.00
Total Long-Term Assets $95.09M $93.80M $316.3M
Total Assets $220.7M $174.6M $316.3M
YoY Change 34.83% -44.79% 1.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $28.39M $28.25M
YoY Change 48.12%
Accrued Expenses $23.45M $20.61M $7.300M
YoY Change 15.02% 182.27% 170.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $700.0K
YoY Change -100.0% -100.0%
Long-Term Debt Due $3.100M $2.900M
YoY Change -58.67%
Total Short-Term Liabilities $59.89M $56.73M $8.000M
YoY Change 6.77% 609.11% 196.3%
LONG-TERM LIABILITIES
Long-Term Debt $49.63M $98.00M $0.00
YoY Change 0.88%
Other Long-Term Liabilities $6.649M $6.391M $5.100M
YoY Change 12.11% 25.31% -53.21%
Total Long-Term Liabilities $56.28M $6.391M $5.100M
YoY Change 848.96% 25.31% -53.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $59.89M $56.73M $8.000M
Total Long-Term Liabilities $56.28M $6.391M $5.100M
Total Liabilities $165.1M $161.8M $13.10M
YoY Change 41.55% 1135.36% -2.96%
SHAREHOLDERS EQUITY
Retained Earnings -$171.0M -$166.6M
YoY Change 31.3%
Common Stock $226.6M $179.4M
YoY Change 27.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $728.5K $728.5K
Shareholders Equity $55.58M $12.81M -$24.23M
YoY Change
Total Liabilities & Shareholders Equity $220.7M $174.6M $316.3M
YoY Change 34.83% -44.79% 1.35%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$4.400M -$10.74M -$13.08M
YoY Change -52.46% -17.87% 142.05%
Depreciation, Depletion And Amortization $2.350M $792.0K $861.0K
YoY Change -66.33% -8.01%
Cash From Operating Activities -$6.400M -$5.460M -$280.0K
YoY Change -89.34% 1850.0% -48.15%
INVESTING ACTIVITIES
Capital Expenditures -$3.450M -$1.280M
YoY Change 85.48%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$3.450M -$1.280M
YoY Change 85.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $50.34M $46.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 47.07M 9.730M 220.0K
YoY Change -41.92% 4322.73%
NET CHANGE
Cash From Operating Activities -6.400M -5.460M -280.0K
Cash From Investing Activities -3.450M -1.280M
Cash From Financing Activities 47.07M 9.730M 220.0K
Net Change In Cash 37.22M 2.990M -60.00K
YoY Change 94.26% -5083.33% -88.89%
FREE CASH FLOW
Cash From Operating Activities -$6.400M -$5.460M -$280.0K
Capital Expenditures -$3.450M -$1.280M
Free Cash Flow -$2.950M -$4.180M
YoY Change -94.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 us-gaap Cash
Cash
22974000
CY2018Q4 us-gaap Cash
Cash
21291000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
80843000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
71131000
CY2019Q3 us-gaap Assets
Assets
174640000
CY2018Q4 us-gaap Assets
Assets
163678000
CY2019Q3 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
20606000
CY2018Q4 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
20388000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
56729000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
56096000
CY2019Q3 us-gaap Liabilities
Liabilities
161832000
CY2018Q4 us-gaap Liabilities
Liabilities
116637000
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
179408000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
177272000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166609000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-130240000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
12808000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
47041000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
174640000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
163678000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8265000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10070000
us-gaap Operating Income Loss
OperatingIncomeLoss
-27705000
us-gaap Operating Income Loss
OperatingIncomeLoss
-47076000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
92276858
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
69496280
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
91182233
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66745895
CY2019Q3 us-gaap Revenues
Revenues
64265000
CY2018Q3 us-gaap Revenues
Revenues
50769000
us-gaap Revenues
Revenues
186336000
us-gaap Revenues
Revenues
129850000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
19131000
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
19477000
us-gaap Cost Of Revenue
CostOfRevenue
55557000
us-gaap Cost Of Revenue
CostOfRevenue
51298000
CY2019Q3 us-gaap Gross Profit
GrossProfit
45134000
CY2018Q3 us-gaap Gross Profit
GrossProfit
31292000
us-gaap Gross Profit
GrossProfit
130779000
us-gaap Gross Profit
GrossProfit
78552000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49475000
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38583000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
147325000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
114483000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3924000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2779000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11159000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7651000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
53399000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
41362000
us-gaap Operating Expenses
OperatingExpenses
158484000
CY2019Q3 us-gaap Interest Expense
InterestExpense
2427000
CY2018Q3 us-gaap Interest Expense
InterestExpense
2940000
us-gaap Operating Expenses
OperatingExpenses
125628000
us-gaap Interest Expense
InterestExpense
6392000
us-gaap Profit Loss
ProfitLoss
-36056000
us-gaap Profit Loss
ProfitLoss
-55576000
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported results of operations during the reporting period. Actual results could differ from those estimates. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1862000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8243000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8418000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35948000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55494000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
108000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-163000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-252000
CY2018Q3 us-gaap Profit Loss
ProfitLoss
-13078000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-820000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-24232000
CY2018Q3 orgo Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
50000
us-gaap Interest Expense
InterestExpense
8131000
orgo Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
299000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2428000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2981000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10693000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13051000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-10741000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-13078000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
82000
us-gaap Net Income Loss
NetIncomeLoss
-36056000
us-gaap Net Income Loss
NetIncomeLoss
-55576000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-57169000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-15317000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
23198000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.83
CY2018Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-45730000
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-45730000
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-33000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-111000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-109000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-242000
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-10741000
orgo Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
-628000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-700000
us-gaap Depreciation
Depreciation
2553000
us-gaap Depreciation
Depreciation
2608000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4526000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2752000
orgo Non Cash Interest Expense
NonCashInterestExpense
196000
orgo Non Cash Interest Expense
NonCashInterestExpense
595000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-29000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-18000
orgo Provision For Inventory Reserve
ProvisionForInventoryReserve
809000
orgo Provision For Inventory Reserve
ProvisionForInventoryReserve
2068000
us-gaap Share Based Compensation
ShareBasedCompensation
700000
us-gaap Share Based Compensation
ShareBasedCompensation
820000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
299000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1862000
orgo Fair Value Adjustment Of Forfeiture Rights
FairValueAdjustmentOfForfeitureRights
589000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-553000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
815000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7840000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-145000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
699000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2665000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5348000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-508000
orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
85000
orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
-675000
orgo Increase Decrease In Accrued Interest Of Affiliate Debt
IncreaseDecreaseInAccruedInterestOfAffiliateDebt
-2859000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-715000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
578000
CY2018Q3 orgo Offering Costs
OfferingCosts
270000
orgo Offering Costs
OfferingCosts
270000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1000
CY2019Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
185000
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
114000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34383000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34077000
CY2019Q3 us-gaap Inventory Net
InventoryNet
20184000
CY2018Q4 us-gaap Inventory Net
InventoryNet
13321000
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3117000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2328000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44254000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39623000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27127000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43230000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2526000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1495000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2776000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1494000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
7000000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
2616000
orgo Proceeds From Affiliates Long Term Debt
ProceedsFromAffiliatesLongTermDebt
15000000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
628000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1754000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2935000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3420000
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3021000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23529000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21405000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2358000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23159000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25887000
us-gaap Interest Paid
InterestPaid
5922000
us-gaap Interest Paid
InterestPaid
3812000
us-gaap Income Taxes Paid
IncomeTaxesPaid
110000
us-gaap Income Taxes Paid
IncomeTaxesPaid
62000
CY2019Q3 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
536000
CY2018Q4 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
477000
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22314000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26091000
CY2019Q3 us-gaap Goodwill
Goodwill
25539000
CY2018Q4 us-gaap Goodwill
Goodwill
25539000
CY2019Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
238000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
238000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
916000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
579000
CY2018Q4 orgo Redeemable Common Stock Liability
RedeemableCommonStockLiability
6762000
CY2018Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2545000
CY2019Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2872000
CY2018Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2236000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
28251000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19165000
CY2019Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
33484000
CY2018Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
26484000
CY2018Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
12578000
CY2019Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
736000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
130000
CY2019Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
14893000
CY2018Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
15418000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6391000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5931000
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
9000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2019Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5000000
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5000000
CY2019Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
37318000
CY2018Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
37497000
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2853000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3420000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3225000
CY2019Q3 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-30000
CY2018Q3 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-51000
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3091000
orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-456000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2935000
orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-116000
CY2019Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
7430000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4711000
CY2019Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1355000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1759000
CY2019Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11399000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6851000
CY2019Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1262000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1206000
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
81130000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
79097000
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
64977000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62435000
CY2019Q3 us-gaap Depreciation
Depreciation
792000
CY2018Q3 us-gaap Depreciation
Depreciation
861000
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20606000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20388000
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15100000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15218000
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5506000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5170000
CY2018Q4 us-gaap Line Of Credit
LineOfCredit
26484000
CY2018Q4 us-gaap Notes Payable
NotesPayable
15885000
CY2018Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2545000
CY2019Q1 us-gaap Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued
BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
728548
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
242000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
252000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
820000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0224
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0274
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M25D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.427
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.429
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
7.08
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
5.40
CY2019Q3 orgo Fair Value Of Common Share
FairValueOfCommonShare
7.08
CY2018Q3 orgo Fair Value Of Common Share
FairValueOfCommonShare
5.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.39
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7266185
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.92
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11150
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.87
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
46000000
CY2019Q3 orgo Working Capital
WorkingCapital
24100000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7263990
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.99
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.59
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.91
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P5Y10M20D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P5Y3M21D
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
32797000
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
28546000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.08
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
91045
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.77
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
33909000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M8D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y2M12D
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
33359000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
538000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
503000
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1444000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M2D
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7263990
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9468807
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1218000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
5714000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
5053000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2558000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
23846000
CY2018Q4 orgo Accrued Legal Expenses
AccruedLegalExpenses
1000000
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
95470290
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91261413
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
94741742
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91261413
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2019Q3 us-gaap Secured Long Term Debt
SecuredLongTermDebt
49599000
us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
332000
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
50000000
CY2019Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-56000
CY2018Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
289000
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15016000
CY2019Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
37330000
CY2019Q3 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
286000
CY2018Q3 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
370000
orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
809000
orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
2068000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
13888000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
16667000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
16667000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
2778000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2019Q3 orgo Shares Reserved For Issuance For Outstanding Options
SharesReservedForIssuanceForOutstandingOptions
6588000
CY2018Q4 orgo Shares Reserved For Issuance For Outstanding Options
SharesReservedForIssuanceForOutstandingOptions
6590195
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22314000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
36580000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10489000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26091000
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1529000
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
918000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5736926
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7025841
CY2019Q3 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
6042000
CY2018Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
5265000
CY2019Q3 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
1180000
CY2019Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
4721000
CY2019Q3 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
4721000
CY2019Q3 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
4945000
CY2019Q3 us-gaap Capital Leases Future Minimum Payments Net Minimum Payments1
CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1
25259000
CY2019Q3 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
7494000
CY2019Q3 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
17765000
CY2019Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2872000
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
263000
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1766000
us-gaap Operating Lease Expense
OperatingLeaseExpense
4993000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1180000
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
8123000
CY2019Q3 orgo Business Combination Contingent Consideration Liability Accrued Interest
BusinessCombinationContingentConsiderationLiabilityAccruedInterest
842000
orgo Write Off Of Deferred Offering Costs
WriteOffOfDeferredOfferingCosts
3494000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
250000
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
500000
CY2019Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
728548
CY2019Q3 orgo Shares Reserved For Issuance For Future Option Grant
SharesReservedForIssuanceForFutureOptionGrant
9008996
CY2018Q4 orgo Shares Reserved For Issuance For Future Option Grant
SharesReservedForIssuanceForFutureOptionGrant
9108996
CY2018Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
17732700
CY2019Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
15596996
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
33431891
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
78111
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
382000
CY2019Q3 us-gaap Interest Payable Current
InterestPayableCurrent
478000
CY2019Q3 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
9692000
CY2019Q3 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11386000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36701000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Reclassification of Prior Period Balances </div></div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Reclassifications have been made to prior period amounts to conform to the current-year presentation of the reporting of deferred interest and principal on outstanding capital lease obligations and deferred tenant escalations as long-term liabilities on the consolidated balance sheets. The deferred interest and tenant escalation amounts were previously reported as accrued expenses on the consolidated balance sheets and the deferred principal on the capital lease obligations were recorded as part of the current portion of capital lease obligations on the consolidated balance sheet. These reclassifications have no effect on the reported net loss or equity for the periods ended September&#160;30, 2018 or December&#160;31, 2018. </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Reclassification has been made to prior period amounts reported in the cash flows from operating activities section of the cash flow statement to conform to the current year presentation. The provision recorded for inventory reserve has been reduced by amounts not related to excess and obsolete inventory and change in inventory has been increased by a corresponding amount. The reclassification has no effect on the reported balance sheet, net loss or equity for the periods ended September&#160;30, 2018 or December&#160;31, 2018. </div></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q3 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
43850000
CY2019Q3 orgo Operating Lease Amount Of Minimum Rental Payments Increase In Each Year In Ten Year Option To Extend
OperatingLeaseAmountOfMinimumRentalPaymentsIncreaseInEachYearInTenYearOptionToExtend
44000
CY2019Q3 orgo Operating Lease Amount Of Minimum Rental Payments Increase In Each Year In Five Year Option To Extend
OperatingLeaseAmountOfMinimumRentalPaymentsIncreaseInEachYearInFiveYearOptionToExtend
33000
CY2019Q3 us-gaap Security Deposit
SecurityDeposit
526000
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001661181
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Trading Symbol
TradingSymbol
ORGO
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Security12b Title
Security12bTitle
Class&#160;A Common Stock
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Shell Company
EntityShellCompany
false
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2019Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2018Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
762000
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
50000000
CY2019Q3 orgo Deemed Dividends To Warrant Holders
DeemedDividendsToWarrantHolders
-645000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
163000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
111000
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
6762000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
863000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
17000
CY2018Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1218000
us-gaap Operating Lease Expense
OperatingLeaseExpense
3630000
CY2019Q3 orgo Accrued Legal Expenses
AccruedLegalExpenses
542000
orgo Proceeds From Notes Payable Net Of Repayments
ProceedsFromNotesPayableNetOfRepayments
5000000
orgo Deemed Dividends To Warrant Holders
DeemedDividendsToWarrantHolders
645000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3698000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
39000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
973000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
270000
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
94743312
CY2019Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
0
orgo Deferred Rent Expense
DeferredRentExpense
606000
orgo Deferred Rent Expense
DeferredRentExpense
42000
orgo Deferred Interest Expense
DeferredInterestExpense
974000
orgo Deferred Interest Expense
DeferredInterestExpense
179000
dei Entity Registrant Name
EntityRegistrantName
Organogenesis Holdings Inc.
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1052000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
924000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
177000
CY2019Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
880000
CY2018Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
581000
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
1991000
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
1304000
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
91000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31657000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
68253000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
17585000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
10000

Files In Submission

Name View Source Status
0001193125-19-289983-index-headers.html Edgar Link pending
0001193125-19-289983-index.html Edgar Link pending
0001193125-19-289983.txt Edgar Link pending
0001193125-19-289983-xbrl.zip Edgar Link pending
d819654d10q.htm Edgar Link pending
d819654dex311.htm Edgar Link pending
d819654dex312.htm Edgar Link pending
d819654dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
orgo-20190930.xml Edgar Link completed
orgo-20190930.xsd Edgar Link pending
orgo-20190930_cal.xml Edgar Link unprocessable
orgo-20190930_def.xml Edgar Link unprocessable
orgo-20190930_lab.xml Edgar Link unprocessable
orgo-20190930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending